James Baumgardner, PhD

home / authors / james-baumgardner-phd

Articles

December 5th 2023

Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C

Jacquelyn W. Chou, MPP, MPL Marlon Graf, PhD Oliver Díaz Espinosa, PhD Iris Brewer, MS Zachary Heim, BS James Baumgardner, PhD

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.

December 11th 2018

Cost Variation and Savings Opportunities in the Oncology Care Model

James Baumgardner, PhD Ahva Shahabi, PhD Christopher Zacker, RPh, PhD Darius Lakdawalla, PhD

Geographic variation in cancer treatment spending reveals that chemotherapy and hospital inpatient care may offer opportunities for savings for practices participating in the Oncology Care Model.

July 13th 2018

Modeling the Impacts of Restrictive Formularies on Patients With HIV

James Baumgardner, PhD Caroline Huber, MPH Mina Kabiri, PhD Lara Yoon, MPH Jacki Chou, MPP, MPL John Romley, PhD

Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.